Kcm Investment Advisors LLC Tyme Technologies, Inc. Transaction History

Kcm Investment Advisors LLC

  • $2.76 Billion
  • Q2 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 12, 2021
BUY
$1.14 - $1.87 $11,399 - $18,700
10,000 New
10,000 $13,000
Q3 2020

Nov 16, 2020
SELL
$0.93 - $1.35 $9,300 - $13,500
-10,000 Closed
0 $0
Q2 2020

Aug 14, 2020
BUY
$0.97 - $1.7 $9,700 - $17,000
10,000 New
10,000 $13,000
Q3 2018

Nov 07, 2018
SELL
$2.18 - $3.44 $21,800 - $34,400
-10,000 Closed
0 $0
Q2 2018

Aug 10, 2018
BUY
$2.05 - $4.09 $20,500 - $40,900
10,000 New
10,000 $32,000

About TYME TECHNOLOGIES, INC.

TYME Quotes by TradingView
  • Ticker TYME
  • Exchange NASDAQ
  • Shares Outstandng 172,207,008
  • Description
  • Tyme Technologies, Inc., a biotechnology company, develops cancer metabolism-based therapies (CMBTs) in the United States. Its lead drug product is SM-88, a CMBT that is in a Phase II/III clinical trial to treat across 15 types of cancer, including pancreatic, prostate, breast, lung, glioma, ovarian, sarcoma, and colon. The company is also devel...
More about TYME
Track This Portfolio

Track Kcm Investment Advisors LLC Portfolio

Follow Kcm Investment Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kcm Investment Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kcm Investment Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email